Delivery Order SPE2DB22D1041-SPE2DB25FUBE8
- Not listed
- The Defense Logistics Agency awarded a $3,415.89 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This firm fixed-price contract, which was not set-aside, represents a small delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency awarded a $1,501.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitive award, which was issued without a set-aside designation, is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,026.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units). This is a non-set-aside competitive award with a completion date of July 25, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,570.39 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order, which carries no set-aside designation, will be performed at the contractor's Conshohocken, Pennsylvania facility. As a child delivery order under a larger contract vehicle, this award represents a specific pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens valued at $1,417.72 on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $4,463.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on July 24, 2025, with a completion date of July 25, 2025. This non-set-aside award was competitively awarded and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $14,246.24 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract vehicle supporting this delivery order is AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $5,756.58 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price contract is a non-set-aside competitive award and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $2,148.90 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract, which is not set-aside and uses firm fixed pricing, is scheduled for completion by July 21, 2025, with performance at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under a larger federal contract vehicle supporting military...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBE8Delivery Order
The Defense Logistics Agency awarded a $35,950.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes management pharmaceutical, reflecting the broader scope of AmerisourceBergen's federal medical supply portfolio, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated sustained capability to meet federal procurement requirements through competitive award mechanisms and maintains a significant role within the DLA's global pharmaceutical supply chain supporting military healthcare systems. The company's IDC vehicle enables flexible fulfillment of medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide. This delivery order exemplifies the routine pharmaceutical procurement activity conducted under the broader pharmaceutical prime vendor framework, which DLA Troop Support is enhancing through its planned Pharmaceutical Prime Vendor Global Program Generation V initiative featuring multiple regional contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.0k | 7/25/25 |